Carvedilol or propranolol in portal hypertension? A randomized comparison

By Hobolth Lise   Møller Søren   Grønbæk Henning   Roelsgaard Klaus   Bendtsen Flemming   Feldager Hansen Erik  

Scandinavian Journal of Gastroenterology, Vol. 47, Iss. 4, 2012-04 ,pp. : 467-474

Informa Healthcare

Access to resources Recommend Favorite

Antiplatelet activity of semotiadil fumarate

By Wolfram R.M.   Kritz H.   Oguogho A.   Sinzinger H.  

Thrombosis Research, Vol. 106, Iss. 4, 2002-05 ,pp. : 187-190

Elsevier

Access to resources Recommend Favorite

Mechanisms Involved in the Antiplatelet Activity of Tetramethylpyrazine in Human Platelets

By Sheu J.-R.   Kan Y.-C.   Hung W.-C.   Ko W.-C.   Yen M.-H.  

Thrombosis Research, Vol. 88, Iss. 3, 1997-11 ,pp. : 259-270

Elsevier

Access to resources Recommend Favorite

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the carvedilol or metoprolol european trial (COMET): randomized controlled trial

By Poole-Wilson P.A.   Swedberg K.   Cleland J.G.F.   for the COMET Investigators  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 45-45

Elsevier

Access to resources Recommend Favorite

Mean platelet volume reproducibility and association with platelet activity and anti-platelet therapy

By Shah Binita   Valdes Vanessa   Nardi Michael A.   Hu Liang   Schrem Ezra   Berger Jeffrey S.  

Platelets, Vol. 25, Iss. 3, 2014-05 ,pp. : 188-192

Informa Healthcare

Access to resources Recommend Favorite